OUTCOME OF BOARD MEETING
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Beryl Drugs Limited held meeting no. 2/2026-2027 on May 28, 2026, from 2:00 PM to 6:30 PM at their registered office in Indore. The board considered and approved the audited financial statements including Balance Sheet, Statement of Profit and Loss, Cash Flow and Notes for the year ended March 31, 2026. The statutory auditors' report for the financial results was also taken on record. Additionally, related party transactions were considered and approved during the meeting. No specific financial figures or audit opinions were disclosed in this filing.
The approval of audited financials indicates routine year-end compliance. The filing does not reveal any adverse audit opinions or specific financial metrics that would signal material concern for shareholders.